1. A case of genotype‐3b hepatitis C virus in which the whole genome was successfully analyzed using third‐generation nanopore sequencing. Issue 9 (13th June 2019) Authors: Uchida, Yoshihito; Kouyama, Jun‐ichi; Naiki, Kayoko; Uemura, Hayato; Tsuji, Shohei; Sugawara, Kayoko; Nakao, Masamitsu; Motoya, Daisuke; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 49:Issue 9(2019) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multicenter pilot survey to clarify the clinical features of patients with acute‐on‐chronic liver failure in Japan. Issue 4 (2nd March 2018) Authors: Nakayama, Nobuaki; Uemura, Hayato; Uchida, Yoshihito; Tomiya, Tomoaki; Ido, Akio; Inoue, Kazuaki; Genda, Takuya; Takikawa, Yasuhiro; Sakaida, Isao; Terai, Shuji; Yokosuka, Osamu; Shimizu, Masahito; Takikawa, Hajime; Mochida, Satoshi Journal: Hepatology research Issue: Volume 48:Issue 4(2018) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis. Issue 11 (26th September 2020) Authors: Uchida, Yoshihito; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Nakao, Masamitsu; Inao, Mie; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 50:Issue 11(2020) Page Start: 1264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis. Issue 12 (21st September 2020) Authors: Uchida, Yoshihito; Inao, Mie; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Nakao, Masamitsu; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 50:Issue 12(2020) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus. Issue 4 (13th January 2020) Authors: Tsuji, Shohei; Uchida, Yoshihito; Uemura, Hayato; Kouyama, Jun‐Ichi; Naiki, Kayoko; Nakao, Masamitsu; Motoya, Daisuke; Sugawara, Kayoko; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 50:Issue 4(2020) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Retreatment with sofosbuvir/ledipasvir with or without lead‐in interferon‐β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy. Issue 4 (20th October 2017) Authors: Uemura, Hayato; Uchida, Yoshihito; Kouyama, Jun‐ichi; Naiki, Kayoko; Yamaba, Shinpei; Fuchigami, Akira; Saito, Yoichi; Shiokawa, Keisuke; Fujii, Yohei; Uchiya, Hiroshi; Nakazawa, Manabu; Ando, Satsuki; Nakao, Masamitsu; Motoya, Daisuke; Sugawara, Kayoko; Inao, Mie; Imai, Yukinori; Nakayama, Nobua... Journal: Hepatology research Issue: Volume 48:Issue 4(2018) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation. Issue 5 (21st February 2022) Authors: Uchida, Yoshihito; Uemura, Hayato; Tsuji, Shohei; Yamada, Shunsuke; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Nakao, Masamitsu; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 52:Issue 5(2022) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate. Issue 3 (9th December 2019) Authors: Uchida, Yoshihito; Nakao, Masamitsu; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Motoya, Daisuke; Sugawara, Kayoko; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Journal of medical virology Issue: Volume 92:Issue 3(2020) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate. Issue 8 (17th April 2020) Authors: Uchida, Yoshihito; Nakao, Masamitsu; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Motoya, Daisuke; Sugawara, Kayoko; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Journal of medical virology Issue: Volume 92:Issue 8(2020) Page Start: 1370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗